Fundamentals

Neurosense Therapeutics Ltd.

NRSN

Soon

Sentiment

Soon

Options

Revenue

0.00

0.000.00%

-

Assets

3.18M

▼-4.69M▼-59.63%

6 Months Change

Liabilities

5.05M

▼-4.36M▼-46.35%

6 Months Change

Free Cash Flow

-8.38M

▼-727.00k▼-9.50%

12 Months Change

Revenue/Cost Of Revenue

Quarterly

Net Profit/Loss

Quarterly

Assets/Liabilities

Quarterly

Cash Flows

Quarterly

Quarterly

Outstanding Shares

Quarterly

Recent Quarterly and Annual Filings

ID: 0001213900-24-030439

ID: 0001213900-23-021883

ID: 0001213900-22-019888